Summarized by Masters of Longevity from PR Newswire.
A news article outlining a new alliance between a CDMO and a CRO to offer integrated development, manufacturing, and clinical support for advanced therapies.
Key Takeaways
- ProBio and Kun Tuo formed a collaboration to provide integrated CMC, nonclinical, and clinical operations support for advanced therapies.
- ProBio has supported over 1,000 GMP batches and contributed to more than 90 IND approvals and IIT programs.
- Kun Tuo, an IQVIA-owned CRO in China, has about 1,000 employees and has supported over 1,400 clinical trials.
